Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
SeaStar Medical Holding ( (ICU) ) has provided an update.
On January 20, 2026, SeaStar Medical Holding disclosed that it had received confirmation from Nasdaq’s Office of General Counsel that the company had regained compliance with Nasdaq Listing Rule 5550(a)(2), which requires a minimum bid price of $1.00 per share. The restored compliance removes the immediate risk of delisting tied to the bid-price deficiency, stabilizing the company’s listing status on Nasdaq and providing greater assurance to shareholders and other market participants about the continued trading of its stock on the exchange.
The most recent analyst rating on (ICU) stock is a Hold with a $2.50 price target. To see the full list of analyst forecasts on SeaStar Medical Holding stock, see the ICU Stock Forecast page.
Spark’s Take on ICU Stock
According to Spark, TipRanks’ AI Analyst, ICU is a Neutral.
The score is held down primarily by persistent operating losses and significant cash burn despite modest revenue, with technicals also reflecting a broader downtrend. Offsetting factors include a cleaner recent balance sheet (no debt, positive equity) and a more constructive earnings call highlighting revenue growth expectations, strong margins, and additional financing to extend runway, though pivotal trial and sales variability risks remain.
To see Spark’s full report on ICU stock, click here.
More about SeaStar Medical Holding
Average Trading Volume: 188,018
Technical Sentiment Signal: Sell
Current Market Cap: $9.61M
For detailed information about ICU stock, go to TipRanks’ Stock Analysis page.